Posts
January 14 2021
Enveric Biosciences, Inc. announced the closing of their Registered Direct offering in the amount of $10,000,000. EG&S acted as counsel to the Placement Agent.
January 14 2021
Lexaria Bioscience Corp. announced the closing of their Underwritten offering in the amount of $11,000,000.00. EG&S acted as counsel to the Underwriter.
January 13 2021
Applied DNA Sciences Inc. announced the closing of their Registered Direct offering in the amount of $15,023,000.00. EG&S acted as counsel to the Placement Agent.
January 13 2021
Bitfarms LTD. announced the closing of their PIPE offering in the amount of CAD$20,000,000. EG&S acted as counsel to the Placement Agent.
January 13 2021
Hut 8 Mining Corp. announced the closing of their PIPE offering in the amount of CAD$77,500,000.00. EG&S acted as counsel to the Placement Agent.
January 12 2021
Global Partner Acquisition Corp II announced the closing of its initial public offering in the amount of $300,000,000. EGS acted as counsel to Global Partner Acquisition Corp II.
January 12 2021
KemPharm, Inc. announced the closing of their Underwritten offering in the amount of $50,000,000.00. EG&S acted as counsel to the Underwriter.
January 12 2021
Sigma Labs, Inc. announced the closing of their Underwritten offering in the amount of $5,135,000.00. EG&S acted as counsel to the Underwriter.